Published by Iain Gilbert on 3rd March 2025
(Sharecast News) - Pharmaceutical giant GSK said on Monday that the US Food and Drug Administration has agreed to review its Biologics License Application for the use of its depemokimab asset in two indications.
URL: http://www.digitallook.com/dl/news/story/34914209/...